Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-06-21 @ 10:22 PM
Study NCT ID:
NCT00131118
Status:
COMPLETED
Last Update Posted:
2017-06-01
First Post:
2005-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CZOL446H2202E1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None